menu
    • menu

    Company profile for Acceleron Pharma

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Acceleron is dedicated to the discovery and development of innovative, life-changing medicines for patients with a wide range of serious and rare diseases. Our research focuses on harnessing the power of the TGF-beta protein superfamily, the target-rich area of biology behind the body’s remarkable capacity for cellular growth and repair. Our approach to drug discovery is driven by deep scientific expertise—and an urgency t...
    Acceleron is dedicated to the discovery and development of innovative, life-changing medicines for patients with a wide range of serious and rare diseases. Our research focuses on harnessing the power of the TGF-beta protein superfamily, the target-rich area of biology behind the body’s remarkable capacity for cellular growth and repair. Our approach to drug discovery is driven by deep scientific expertise—and an urgency to deliver effective treatments to thousands of patients who have few or no therapeutic options.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Acceleron PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    128 Sidney Street Cambridge, MA 02139
    Telephone
    Telephone
    617-649-9200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://acceleronpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/acceleron-pharma
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AcceleronPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Even after Prometheus, Acceleron deals, Merck primed for M&A
    Even after Prometheus, Acceleron deals, Merck primed for M&A

    01 Feb 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/merck-still-market-deals-1b-15b-range-ceo-says

    FIERCE PHARMA
    01 Feb 2024
    Share Share
    Merck unwraps full PIII data on the centerpiece from its $11.5B Acceleron buyout
    Merck unwraps full PIII data on the centerpiece from its $11.5B Acceleron buyout

    07 Mar 2023

    // ENDPTS

    https://endpts.com/merck-unwraps-full-phiii-data-on-the-centerpiece-from-its-11-5b-acceleron-buyout-acc23/

    ENDPTS
    07 Mar 2023
    Share Share
    Early look at how Merck & Co.’s sotatercept could impact PAH space
    Early look at how Merck & Co.’s sotatercept could impact PAH space

    17 Oct 2022

    // FIRSTWORLDPHARMA

    https://firstwordpharma.com/story/5664440

    FIRSTWORLDPHARMA
    17 Oct 2022
    Share Share
    Merck nails phase 3 sotatercept win a year after acquiring it
    Merck nails phase 3 sotatercept win a year after acquiring it

    11 Oct 2022

    // Max Bayer FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/merck-nails-phase-3-sotatercept-win-year-after-acquiring-it-acceleron

    Max Bayer FIERCEBIOTECH
    11 Oct 2022
    Share Share
    Celgene, Acceleron alum Backstrom tapped to lead Scholar Rock
    Celgene, Acceleron alum Backstrom tapped to lead Scholar Rock

    20 Sep 2022

    // Max Bayer FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/celgene-acceleron-alum-backstrom-tapped-be-top-purveyor-scholar-rock

    Max Bayer FIERCEBIOTECH
    20 Sep 2022
    Share Share
    FDA warns small biotech Ocugen of potential $10K fines for failing
    FDA warns small biotech Ocugen of potential $10K fines for failing

    25 Apr 2022

    // Zachary Brennan ENDPTS

    https://endpts.com/fda-warns-small-biotech-ocugen-of-potential-10k-fines-for-failing-to-post-trial-results/

    Zachary Brennan ENDPTS
    25 Apr 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search